Effects of pre‐freeze pathogen reduction with riboflavin and UV light on red cells stored post‐thaw in AS ‐3 additive solution
Transfusion · 2023
DOI: 10.1111/trf.17313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von Dominik Kutac und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Transfusion, Military University Hospital, Prague, Czech Republic. Hauptthemen laut MEDLINE: Hemolysis, Ultraviolet Rays. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Pathogen reduction technology (PRT) may improve the safety of RBCs for transfusion. As the Czech Republic considers PRT, we asked what effects riboflavin and UV light PRT pre‐freezing has on the post‐thaw recovery and properties of cryopreserved RBCs (CRBCs) after deglycerolization and liquid storage. Study Design and Methods 24 Group O whole blood (WB) units were leukoreduced and then treated with riboflavin and UV light PRT (Mirasol, Terumo BCT, USA) before cryopreservation (T‐CRBC); 20 similarly‐collected units were untreated controls (C‐CRBC). Units were processed to RBCs and then cryopreserved with 40% glycerol (wt/vol), frozen at −80°C, stored >118 days, reconstituted as deglycerolized RBC units in AS‐3, and stored at 4 ± 2°C for 21 days. One treated unit sustained massive hemolysis during the post‐thaw wash process and was removed from data analysis. The remaining units were assessed pre‐PRT, post‐PRT, and post‐thaw‐wash on days 0, 7, 14, and 21 for hematocrit, volume, hemoglobin per transfusion unit, pH, % hemolysis, hemoglobin in the supernatant, potassium, phosphorus, NH 3 , osmolality, ATP, and 2,3‐diphosphoglycerate.
Results
PRT with leukoreduction caused a 5% loss of RBC followed by a 24% freeze–thaw‐wash related loss for a total 28% loss but treated units contained an average of 45 g of hemoglobin, meeting European Union guidelines for CRBC. T‐CRBCs displayed higher post‐wash hemolysis, potassium, and ammonia concentrations, and lower ATP at the end of storage.
Conclusions
Cryopreserved RBCs from Riboflavin and UV light‐treated WB meet the criteria for clinical use for 7 days after thawing and provide additional protection against infectious threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Transfusion, Military University Hospital, Prague, Czech Republic.
- Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
- Faculty of Biomedical Engineering, Czech Technical University, Prague, Czech Republic.
- Department of Biochemistry, St. Sisters of Mercy Hospital Karel Boromejsky, Prague, Czech Republic.
- Department of Internal Medicine IV - Hematology, University Hospital, Hradec Kralove, Czech Republic.
- Harborview Injury Prevention and Research Center, Harborview Medical Center, Seattle, Washington, USA.
ORCID-Profile: Dominik Kutac, John R Hess
Zitieren
APA
Kutac, D., Bohonek, M., Landova, L., Staskova, E., Blahutova, M., Lovecky, J., Horacek, J. M., Stansbury, L. G., & Hess, J. R. (2023). Effects of pre‐freeze pathogen reduction with riboflavin and UV light on red cells stored post‐thaw in AS ‐3 additive solution. Transfusion. https://doi.org/10.1111/trf.17313
Vancouver
Kutac D, Bohonek M, Landova L, Staskova E, Blahutova M, Lovecky J, et al. Effects of pre‐freeze pathogen reduction with riboflavin and UV light on red cells stored post‐thaw in AS ‐3 additive solution. Transfusion. 2023. doi:10.1111/trf.17313
BibTeX
@article{Kutac2023,
author = {Kutac, Dominik and Bohonek, Milos and Landova, Ludmila and Staskova, Eva and Blahutova, Marie and Lovecky, Juraj and Horacek, Jan M and Stansbury, Lynn G and Hess, John R},
title = {Effects of pre‐freeze pathogen reduction with riboflavin and UV light on red cells stored post‐thaw in AS ‐3 additive solution},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17313}
}
EUVIMED